News and information on generic drugs sold in retail pharmacies, as well as their suppliers.
House Democrats have secured multiple policy changes in the USMCA, including those related to prescription drug pricing,
Afinitor 2.5 mg, 5 mg and 7 mg tablets had a market value of roughly $412 million over the last four quarters, according to IQVIA.
Fresenius Kabi's generic Invanz is available in a 1-g vial.
Amgen's biosimilar Avsola offers a biological treatment option to patients across critical disease states, including chronic inflammatory conditions.
NuvaRing had a market value of roughly $976 million for the 12 months ended Oct. 31, 2019, according to IQVIA.
Blink Health is offering new patients more than 4,000 medications for free.
Amneal has received the Food and Drug Administration’s clearance for three generics that it is introducing immediately, including the first generic of Carafate (sucralfate oral suspension).
Exjade had a market value of roughly $113 million and Jadenu had a market value of about $470 million for the most recent 12 months ended in September.
The FDA has approved three applications for first generics of Novartis’ Gilenya (fingolimod) capsules for relapsing forms of multiple sclerosis in adult patients.
The generic of Novartis’ branded product will be available in dosage strengths of 90- and 360-mg.
Mylan's Ogivri is available in 420 mg multidose vials and 150 mg single-dose vials.
The Exelon Patch and its generics had a market value of $161 million for the 12 months ended Sept. 30, 2019.
Erlotinib has a market value of approximately $150 million annually, according to sales data.
Aurobindo took home the Company of the Year and Acquisition of the Year awards at the event, which was held Nov. 5 in Frankfurt, Germany.
Branded Glumetza saw sales of $226.7 million in the year ended September 2019, according to IQVIA data.
Hydrocortisone valerate cream 0.2% had a market value of roughly $11.5 million, according to IQVIA September 2019 data.
STI Pharma is launching its first oncology injectable with the introduction of its generic of Bicnu (carmustine for injection)
Pfizer plans to launch Humira biosimilar in 2023.
Hectorol injection single-dose vials and multidose vials brand and generics had a market value of approximately $138 million for the most recent 12 months ending in September 2019, according to IQVIA.
Public quality standards set forth by USP increased competition in the generic medicines market and reduced overall prescription drug costs by $11 billion in 2015 and 2016.
Zydus Cadila's generic Otezla provides a treatment for psoriatic arthritis, and mouth sores for people with Behcet's disease.
Potassium chloride for oral solution, 20 mEq, had a market value of roughly $90 million, according to IQVIA data from September 2019.
Fresenius Kabi's generic Emend provides clinicians with a treatment alternative that has a 24-month shelf life.
Epiduo gel had a market value of about $33.7 million for the 12 month period ended September 2019, according to IQVIA.
Eli Kalif will join Teva as executive vice president and chief financial officer on Dec. 22.
Tarceva and its generics had a market value of approximately $145 million during the year ended Sept, 30, 2019.